Literature DB >> 18543043

Usefulness of automatic quantification of immunochemical staining on whole tumor sections for correlation with oncological small animal PET studies: an example with cell proliferation, glucose transporter 1 and FDG.

Nicolas Aide1, Alexandre Labiche, Paulette Herlin, Maria Paciencia, Laurent Poulain, Soizic Dutoit, Françoise Montravers, Pascal Gauduchon, Jacques Chasle.   

Abstract

AIM: To highlight the use of automatic quantification of immunochemical staining on digitized images of whole tumor sections in preclinical positron emission tomography (PET) studies.
MATERIALS AND METHODS: Xenografted human testicular tumors (36) were imaged with 2-deoxy-2[F-18]fluoro-D: -glucose (FDG) small animal PET (SA-PET). Tumor cell proliferation and glucose transportation were assessed with cyclin A and Glut-1 immunostaining. Tumor slides were digitized and processed with PixCyt software enabling whole slide quantification, then compared with junior and senior pathologist manual scoring. Manual and automatic quantification results were correlated to FDG uptake.
RESULTS: For cyclin A, inter- and intra-observer agreement for manual scoring was 0.52 and 0.72 and concordance between senior pathologist and automatic quantification was 0.84. Correlations between Tumor/Background ratio and tumor cell proliferation assessed by automatic quantification, junior and senior pathologists were 0.75, 0.55, and 0.61, respectively. Correlation between Tumor/Background ratio and Glut-1 assessed by automatic quantification was 0.74.
CONCLUSION: Automatic quantification of immunostaining is a valuable tool to overcome inter- and intra-observer variability for correlation of cell proliferation or other markers with tumor tracer uptake.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18543043     DOI: 10.1007/s11307-008-0144-5

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  23 in total

1.  Role of small animal PET for molecular imaging in pre-clinical studies.

Authors:  Cristina Nanni; Domenico Rubello; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-03-10       Impact factor: 9.236

2.  Pleiotrophin, a candidate gene for poor tumor vasculature and in vivo neuroblastoma sensitivity to irinotecan.

Authors:  L Calvet; B Geoerger; M Regairaz; P Opolon; L Machet; J Morizet; J-M Joseph; N Elie; G Vassal
Journal:  Oncogene       Date:  2006-05-25       Impact factor: 9.867

3.  Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography.

Authors:  H Vesselle; R A Schmidt; J M Pugsley; M Li; S G Kohlmyer; E Vallires; D E Wood
Journal:  Clin Cancer Res       Date:  2000-10       Impact factor: 12.531

4.  Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033.

Authors:  Donna S Dorow; Carleen Cullinane; Nelly Conus; Peter Roselt; David Binns; Timothy J McCarthy; Grant A McArthur; Rodney J Hicks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02-01       Impact factor: 9.236

5.  Effect of corticosteroids on 18F-FDG uptake in tumor lesions after chemotherapy.

Authors:  Lieselot Brepoels; Sigrid Stroobants; Peter Vandenberghe; Karoline Spaepen; Patrick Dupont; Johan Nuyts; Guy Bormans; Luc Mortelmans; Gregor Verhoef; Christiane De Wolf-Peeters
Journal:  J Nucl Med       Date:  2007-03       Impact factor: 10.057

6.  An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development.

Authors:  Carleen Cullinane; Donna S Dorow; Maya Kansara; Nelly Conus; David Binns; Rodney J Hicks; Leonie K Ashman; Grant A McArthur; David M Thomas
Journal:  Cancer Res       Date:  2005-11-01       Impact factor: 12.701

7.  Progesterone receptor in non-small cell lung cancer--a potent prognostic factor and possible target for endocrine therapy.

Authors:  Hironori Ishibashi; Takashi Suzuki; Satoshi Suzuki; Hiromichi Niikawa; Liangying Lu; Yasuhiro Miki; Takuya Moriya; Shin-Ichi Hayashi; Masashi Handa; Takashi Kondo; Hironobu Sasano
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

8.  A simple way of quantifying immunostained cell nuclei on the whole histologic section.

Authors:  Nicolas Elie; Benoît Plancoulaine; Jehan-Pierre Signolle; Paulette Herlin
Journal:  Cytometry A       Date:  2003-11       Impact factor: 4.355

9.  Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography.

Authors:  R Kubota; S Yamada; K Kubota; K Ishiwata; N Tamahashi; T Ido
Journal:  J Nucl Med       Date:  1992-11       Impact factor: 10.057

Review 10.  Cyclin A in cell cycle control and cancer.

Authors:  C H Yam; T K Fung; R Y C Poon
Journal:  Cell Mol Life Sci       Date:  2002-08       Impact factor: 9.261

View more
  2 in total

1.  Early evaluation of the effects of chemotherapy with longitudinal FDG small-animal PET in human testicular cancer xenografts: early flare response does not reflect refractory disease.

Authors:  Nicolas Aide; Laurent Poulain; Mélanie Briand; Soizic Dutoit; Stéphane Allouche; Alexandre Labiche; Aurélie Ngo-Van Do; Valérie Nataf; Alain Batalla; Pascal Gauduchon; Jean-noël Talbot; Françoise Montravers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-12-03       Impact factor: 9.236

2.  Evaluation of the specificity of [(18)F]fludarabine PET/CT in a xenograft model of follicular lymphoma: comparison with [(18)F]FDG and impact of rituximab therapy.

Authors:  Narinée Hovhannisyan; Stéphane Guillouet; Fabien Fillesoye; Martine Dhilly; Delphine Patin; Françoise Galateau; Michel Leporrier; Louisa Barré
Journal:  EJNMMI Res       Date:  2015-04-14       Impact factor: 3.138

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.